The interferon regulatory factors and oncogenesis

Seminars in Cancer Biology

Volumn 10, Issue 2, 2000, Pages 73-81

  Tanaka, Nobuyuki ^a   Taniguchi, Tadatsugu ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Gene regulation; Interferon; IRF; Oncogenesis

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CASPASE; INTERFERON CONSENSUS SEQUENCE BINDING PROTEIN; INTERFERON REGULATORY FACTOR 1; INTERFERON REGULATORY FACTOR 2; PROTEIN LYSINE 6 OXIDASE; PROTEIN P21; TRANSCRIPTION FACTOR;

APOPTOSIS; CANCER INHIBITION; CARCINOGENESIS; CELL CYCLE; CELL GROWTH; GENE CONTROL; GROWTH REGULATION; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; NONHUMAN; PATHOPHYSIOLOGY; REVIEW; TUMOR SUPPRESSOR GENE;

EID: 0033939557     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1006/scbi.2000.0310     Document Type: Article

References (89)

1. Hanahan D, Weinberg R A. The hallmarks of cancer. Cell. 100:2000;57-70.
2. Hunter T. Oncoprotein networks. Cell. 88:1997;333-346.
3. Rabbitts T H. Chromosomal translocations in human cancer. Nature. 372:1994;143-149.
4. Adams J M, Cory S. Transgenic models of tumor development. Science. 254:1991;1161-1167.
5. Ghebranious N, Donehower L A. Mouse models in tumor suppression. Oncogene. 17:1998;3385-3400.
6. De Maeyer E, De Maeyer-Guignard J. Interferons and Other Regulatory Cytokines. 1988;John Wiley and Sons, New York.
7. Vilcek J, Sen G S. Fields D M, Knipe P M, Howley P M. Fields Virology. 1996;375-399 Lippincott-Raven, Philadelphia.
8. Miyamoto M, Fujita T, Kimura Y, Maruyama M, Harada H, Sudo Y, Miyata T, Taniguchi T. Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-b gene regulatory elements. Cell. 54:1988;903-913.
9. Harada H, Fujita T, Miyamoto M, Kimura Y, Maruyama M, Furia A, Miyata T, Taniguchi T. Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes. Cell. 58:1989;729-739.
10. Taniguchi T, Lamphier M S, Tanaka N. IRF-1: the transcription factor linking the interferon response and oncogenesis. Biochim Biophys Acta. 1333:1997;M9-M17.
11. Tanaka N, Kawakami T, Taniguchi T. Recognition DNA sequences of interferon regulatory factor 1 (IRF-1) and IRF-2, regulators of cell growth and the interferon system. Mol Cell Biol. 13:1993;4531-4538.
12. Bluyssen A R, Durbin J E, Levy D E. ISGF3 γ p48, a specificity switch for interferon activated transcription factors. Cytokine Growth Factor Rev. 7:1996;11-17.
13. Nguyen H, Hiscott J, Pitha P M. The growing family of interferon regulatory factors. Cytokine Growth Factor Rev. 8:1997;293-312.
14. Mamane Y, Heylbroeck C, Genin P, Algarte M, Servant M J, LePage C, DeLuca C, Kwon H, Lin R, Hiscott J. Interferon regulatory factors: the next generation. Gene. 237:1999;1-14.
15. Moore P S, Boshoff C, Weiss R A, Chang Y. Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science. 274:1996;1739-1744.
16. Escalante C R, Yie J, Thanos D, Aggarwal A K. Structure of IRF-1 with bound DNA reveals determinants of interferon regulation. Nature. 391:1998;103-106.
17. Darnell J E Jr, Kerr I M, Stark G R. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science. 264:1994;1415-1421.
18. Driggers P H, Ennist D L, Gleason S L, Mak W-H, Marks M S, Levi B-Z, Flanagan J R, Appella E, Ozato K. An interferon γ -regulated protein that binds the interferon-inducible enhancer element of major histocompatibility complex class I genes. Proc Natl Acad Sci USA. 87:1990;3743-3747.
19. Goodbourn S, Zinn K, Maniatis T. Human β -interferon gene expression is regulated by an inducible enhancer element. Cell. 41:1985;509-520.
20. Goodbourn S, Maniatis T. Overlapping positive and negative regulatory domains of the human β -interferon gene. Proc Natl Acad Sci USA. 85:1988;1447-1451.
21. Harada H, Willison K, Sakakibara J, Miyamoto M, Fujita T, Taniguchi T. Absence of the type-I IFN system in EC cells: transcriptional activator (IRF-1) and repressor (IRF-2) genes are developmentally regulated. Cell. 63:1990;303-312.
22. Fujita T, Kimura Y, Miyamoto M, Barsoumian E L, Taniguchi T. Induction of endogenous IFN- α and IFN- β genes by a regulatory transcription factor, IRF-1. Nature. 337:1989;270-272.
23. Fujita T, Reis L F, Watanabe N, Kimura Y, Taniguchi T, Vilcek J. Induction of the transcription factor IRF-1 and interferon- β mRNAs by cytokines and activators of second-messenger pathways. Proc Natl Acad Sci USA. 86:1989;9936-9940.
24. Abdollahi A, Lord K A, Hoffman-Liebermann B, Liebermann D A. Interferon regulatory factor 1 is a myeloid differentiation primary response gene induced by interleukin 6 and leukemia inhibitory factor: role in growth inhibition. Cell Growth Differ. 2:1991;401-407.
25. Harada H, Kondo T, Ogawa S, Tamura T, Kitagawa M, Tanaka N, Lamphier M S, Hirai H, Taniguchi T. Accelerated exon skipping of IRF-1 mRNA in human myelodysplasia/leukemia; a possible mechanism of tumor suppressor inactivation. Oncogene. 9:1994;3313-3320.
26. Pine R, Canova A, Schindler C. Tyrosine phosphorylated p91 binds to a single element in the ISGF2/IRF-1 promoter to mediate induction by IFN alpha and IFN gamma, and is likely to autoregulate the p91 gene. EMBO J. 13:1994;158-167.
27. Kamijo R, Harada H, Matsuyama T, Bosland M, Gerecitano J, Shapiro D, Le J, Koh S I, Kimura T, Green S J, Mak T W, Taniguchi T, Vlicek J. Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science. 263:1994;1612-1615.
28. Kimura T, Nakayama K, Penninger J, Kitagawa M, Harada H, Matsuyama T, Tanaka N, Kamijo R, Vilcek J, Mak T W, Taniguchi T. Involvement of the IRF-1 transcription factor in antiviral responses to interferons. Science. 264:1994;1921-1924.
29. Harada H, Kitagawa M, Tanaka N, Yamamoto H, Harada K, Ishihara M, Taniguchi T. Anti-oncogenic and oncogenic potentials of interferon regulatory factors-1 and -2. Science. 259:1993;971-974.
30. Tanaka N, Ishihara M, Lamphier M S, Nozawa H, Matsuyama T, Mak T W, Aizawa S, Tokino T, Oren M, Taniguchi T. Cooperation of the tumor suppressors IRF-1 and p53 in response to DNA damage. Nature. 382:1996;816-818.
31. Clarke A R, Purdie C A, Harrison D J, Morris R G, Bird C C, Hooper M L, Wyllie A H. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature. 362:1993;849-852.
32. Lowe S W, Schmitt E M, Smith S W, Osborne B A, Jacks T. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature. 362:1993;847-849.
33. Strasser A, Harris A W, Jacks T, Cory S. DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2. Cell. 79:1994;329-339.
34. Tamura T, Ishihara M, Lamphier M S, Tanaka N, Oishi I, Aizawa S, Matsuyama T, Mak T W, Taki S, Taniguchi T. An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes. Nature. 376:1995;596-599.
35. Tanaka N, Ishihara M, Taniguchi T. Suppression of c-myc or fosB-induced cell transformation by the transcription factor IRF-1. Cancer Lett. 83:1994;191-196.
36. Weinberg R A. The action of oncogenes in the cytoplasm and nucleus. Science. 230:1985;770-776.
37. Weinberg R A. Oncogenes, antioncogenes, and the molecular basis of multistep carcinogenesis. Cancer Res. 49:1989;3713-3721.
38. Tanaka N, Ishihara M, Kitagawa M, Harada H, Kimura T, Matsuyama T, Lamphier M S, Aizawa S, Mak T W, Taniguchi T. Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1. Cell. 77:1994;829-839.
39. Nozawa H, Oda E, Nakao K, Ishihara M, Ueda S, Yokochi T, Ogasawara K, Nakatsuru Y, Shimizu S, Ohira Y, Hioki K, Aizawa S, Ishikawa T, Katsuki M, Muto T, Taniguchi T, Tanaka N. Loss of transcription factor IRF-1 affects tumor susceptibility in mice carrying the Ha-ras transgene or nullizygosity for p53. Genes Dev. 13:1999;1240-1245.
40. Tan R S, Taniguchi T, Harada H. Identification of the lysyl oxidase gene as target of the antioncogenic transcription factor, IRF-1, and its possible role in tumor suppression. Cancer Res. 56:1996;2417-2421.
41. Kenyon K, Contente S, Trackman P C, Tang J, Kagan H M, Friedman R M. Lysyl oxidase and rrg messenger RNA. Science. 253:1991;802.
42. Contente S, Kenyon K, Rimoldi D, Friedman R M. Expression of gene rrg is associated with reversion of NIH 3T3 transformed by LTR-c-H-ras. Science. 249:1990;796-798.
43. Itoh S, Harada H, Nakamura Y, White R, Taniguchi T. Assignment of the human interferon regulatory factor-1 (IRF1) gene to chromosome 5q23-q31. Genomics. 10:1991;1097-1099.
44. Willman C L, Sever C E, Pallavicini M G, Harada H, Tanaka N, Slovak M L, Yamamoto H, Harada K, Meeker T C, List A F, Taniguchi T. Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia. Science. 259:1993;968-971.
45. VandenBerghe H, Vermaelen K, Mecucci C, Barbieri D, Tricot G. The 5q- anormaly. Cancer Genet Cytogenet. 17:1985;189-255.
46. Boultwood J, Fidler C, Lewis S, MacCarthy A, Sheridan H, Kelly S, Oscier D, Buckle V J, Wainscoat J S. Allelic loss of IRF1 in myelodysplasia and acute myeloid leukemia: Retention of IRF1 on the 5q-chromosome in some patients with the 5q-syndrome. Blood. 82:1993;2611-2616.
47. Ogasawara S, Tamura G, Maesawa C, Suzuki Y, Ishida K, Satoh N, Uesugi N, Saito K, Satodate R. Common deleted region on the long arm of chromosome 5 in esophageal carcinoma. Gastroenterology. 110:1996;52-57.
48. Tamura G, Ogasawara S, Nishizuka S, Sakata K, Maesawa C, Suzuki Y, Terashima M, Saito K, Satodate R. Two distinct regions of deletion on the long arm of chromosome 5 in differentiated adenocarcinomas of the stomach. Cancer Res. 56:1996;612-615.
49. Nozawa H, Oda E, Ueda S, Tamura G, Maesawa C, Muto T, Taniguchi T, Tanaka N. Functionally inactivating point mutation in the tumor-suppressor IRF-1 gene identified in human gastric cancer. Int J Cancer. 77:1998;522-527.
50. Kondo T, Minamino N, Nagamura-Inoue T, Matsumoto M, Taniguchi T, Tanaka N. Identification and characterization of nucleophosmin/B23/numatrin which binds the anti-oncogenic transcription factor IRF-1 and manifests oncogenic activity. Oncogene. 15:1997;1275-1281.
51. Mayeda A, Helfman D M, Krainer A R. Modulation of exon skipping and inclusion by heterogeneous nuclear ribonucleoprotein A1 and pre-mRNA splicing factor SF2/ASF. Mol Cell Biol. 13:1993;2993-3001.
52. Fearon D T, Locksley R M. The instructive role of innate immunity in the acquired immune response. Science. 272:1996;50-54.
53. Lohoff M, Ferrick D, Mittrucker H W, Duncan G S, Bischof S, Rollinghoff M, Mak T W. Interferon regulatory factor-1 is required for a T helper 1 immune response in vivo. Immunity. 6:1997;681-689.
54. Taki S, Sato T, Ogasawara K, Fukuda T, Sato M, Hida S, Suzuki G, Mitsuyama M, Shin E H, Kojima S, Taniguchi T, Asano Y. Multistage regulation of Th1-type-Immune responses by the transcription factor IRF-1. Immunity. 6:1997;673-679.
55. MacMicking J, Xie Q W, Nathan C. Nitric oxide and macrophage function. Annu Rev Immunol. 15:1997;323-350.
56. Trinchieri G. Biology of natural killer cells. Adv Immunol. 47:1989;187-376.
57. Ogasawara K, Hida S, Azimi N, Tagaya Y, Sato T, Yokochi-Fukuda T, Waldmann T A, Taniguchi T, Taki S. Requirement for IRF-1 in the microenvironment supporting development of natural killer cells. Nature. 391:1998;700-703.
58. Harada H, Takahashi E, Itoh S, Harada K, Hori T A, Taniguchi T. Structure and regulation of the human interferon regulatory factor 1 (IRF-1) and IRF-2 genes: implications for a gene network in the interferon system. Mol Cell Biol. 14:1994;1500-1509.
59. Nguyen H, Mustafa A, Hiscott J, Lin R. Transcription factor IRF-2 exerts its oncogenic phenotype through the DNA binding/transcription repression domain. Oncogene. 11:1995;537-544.
60. Vaughan P S, Aziz F, van Wijnen A J, Wu S, Harada H, Taniguchi T, Soprano K J, Stein J L, Stein G S. Activation of a cell-cycle-regulated histone gene by the oncogenic transcription factor IRF-2. Nature. 377:1995;362-365.
61. Vaughan P S, van der Meijden C M, Aziz F, Harada H, Taniguchi T, van Wijnen A J, Stein J L, Stein G S. Cell cycle regulation of histone H4 gene transcription requires the oncogenic factor IRF-2. J Biol Chem. 273:1998;194-199.
62. Nelson N, Kanno Y, Hong C, Contursi C, Fujita T, Fowlkes B J, O'Connell E, Hu- Li J, Paul W E, Jankovic D, Sher A F, Coligan J E, Thornton A, Appella E, Yang Y, Ozato K. Expression of IFN regulatory factor family proteins in lymphocytes. Induction of Stat-1 and IFN consensus sequence binding protein expression by T cell activation. J Immunol. 156:1996;3711-3720.
63. Sharf R, Azriel A, Lejbkowicz F, Winograd S S, Ehrlich R, Levi B Z. Functional domain analysis of interferon consensus sequence binding protein (ICSBP) and its association with interferon regulatory factors. J Biol Chem. 270:1995;13063-13069.
64. Eklund E A, Jalava A, Kakar R. PU.1, interferon regulatory factor 1, and interferon consensus sequence-binding protein cooperate to increase gp91(phox) expression. J Biol Chem. 273:1998;13957-13965.
65. Holtschke T, Lhler J, Kanno Y, Fehr T, Giese N, Rosenbauer F, Lou J, Knobeloch K- P, Gabriele L, Waring J F, Bachmann M F, Zinkernagel R M, Morse III H C, Ozato K, Horak I. Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene. Cell. 87:1996;307-317.
66. Sharf R, Meraro D, Azriel A, Thornton A M, Ozato K, Petricoin E F, Larner A C, Schaper F, Hauser H, Levi B Z. Phosphorylation events modulate the ability of interferon consensus sequence binding protein to interact with interferon regulatory factors and to bind DNA. J Biol Chem. 272:1997;9785-9792.
67. Schmidt M, Nagel S, Proba J, Thiede C, Ritter M, Waring J F, Rosenbauer F, Huhn D, Wittig B, Horak I, Neubauer A. Lack of interferon consensus sequence binding protein (ICSBP) transcripts in human myeloid leukemias. Blood. 91:1998;22-29.
68. Hao S X, Ren R. Expression of interferon consensus sequence binding protein (ICSBP) is downregulated in Bcr-Abl-induced murine chronic myelogenous leukemia-like disease, and forced coexpression of ICSBP inhibits Bcr-Abl-induced myeloproliferative disorder. Mol Cell Biol. 20:2000;1149-1161.
69. Eisenbeis C F, Singh H, Storb U. Pip, a novel IRF family member, is a lymphoid-specific, PU.1-dependent transcriptional activator. Genes Dev. 9:1995;1377-1387.
70. Matsuyama T, Grossman A, Mittrucker H W, Siderovski D P, Kiefer F, Kawakami T, Richardson C D, Taniguchi T, Yoshinaga S K, Mak T W. Molecular cloning of LSIRF, a lymphoid-specific member of the interferon regulatory factor family that binds the interferon-stimulated response element (ISRE). Nucleic Acids Res. 23:1995;2127-2136.
71. Yamagata T, Nishida J, Tanaka S, Sakai R, Mitani K, Yoshida M, Taniguchi T, Yazaki Y, Hirai H. A novel interferon regulatory factor family transcription factor, ICSAT/Pip/LSIRF, that negatively regulates the activity of interferon-regulated genes. Mol Cell Biol. 16:1996;1283-1294.
72. Mittrucker H W, Matsuyama T, Grossman A, Kundig T M, Potter J, Shahinian A, Wakeham A, Patterson B, Ohashi P S, Mak T W. Requirement for the transcription factor LSIRF/IRF4 for mature B and T lymphocyte function. Science. 275:1997;540-543.
73. Iida S, Rao P H, Butler M, Corradini P, Boccadoro M, Klein B, Chaganti R S, Dalla-Favera R. Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myeloma. Nat Genet. 17:1997;226-230.
74. Saito T, Yamagata T, Takahashi T, Honda H, Hirai H. ICSAT overexpression is not sufficient to cause adult T-cell leukemia or multiple myeloma. Biochem Biophys Res Commun. 260:1999;329-331.
75. Felsher D W, Bishop J M. Reversible tumorigenesis by MYC in hematopoietic lineages. Mol Cell. 4:1999;199-207.
76. Veals S A, Schindler C, Leonard D, Fu X Y, Aebersold R, Darnell J E Jr, Levy D E. Subunit of an a-interferon-responsive transcription factor is related to interferon regulatory factor and Myb families of DNA-binding proteins. Mol Cell Biol. 12:1992;3315-3324.
77. Matikainen S, Ronni T, Lehtonen A, Sareneva T, Melen K, Nordling S, Levy D E, Julkunen I. Retinoic acid induces signal transducer and activator of transcription (STAT) 1, STAT2, and p48 expression in myeloid leukemia cells and enhances their responsiveness to interferons. Cell Growth Differ. 8:1997;687-698.
78. Weihua X, Lindner D J, Kalvakolanu D V. The interferon-inducible murine p48 (ISGF3 γ) gene is regulated by protooncogene c-myc. Proc Natl Acad Sci USA. 94:1997;7227-7232.
79. Gao S J, Boshoff C, Jayachandra S, Weiss R A, Chang Y, Moore P S. KSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway. Oncogene. 15:1997;1979-1985.
80. Burysek L, Yeow W S, Pitha P M. Unique properties of a second human herpesvirus 8-encoded interferon regulatory factor (vIRF-2). J Hum Virol. 2:1999;19-32.
81. Moore P S, Chang Y. Antiviral activity of tumor-suppressor pathways: clues from molecular piracy by KSHV. Trends Genet. 14:1998;144-150.
82. Weaver B K, Kumar K P, Reich N C. Interferon regulatory factor 3 and CREB-binding protein/p300 are subunits of double-stranded RNA-activated transcription factor DRAF1. Mol Cell Biol. 18:1998;1359-1368.
83. Yamagata T, Nishida J, Tanaka S, Sakai R, Mitani K, Yoshida M, Taniguchi T, Yazaki Y, Hirai H. A novel interferon regulatory factor family transcription factor, ICSAT/Pip/LSIRF, that negatively regulates the activity of interferon-regulated genes. Mol Cell Biol. 16:1996;1283-1294.
84. Sato M, Tanaka N, Hata N, Oda E, Taniguchi T. Involvement of the IRF family transcription factor IRF-3 in virus-induced activation of the IFN-b gene. FEBS Lett. 425:1998;112-116.
85. Wathelet M G, Lin C H, Parekh B S, Ronco L V, Howley P M, Maniatis T. Virus infection induces the assembly of coordinately activated transcription factors on the IFN- β enhancer in vivo. Mol Cell. 1:1998;507-518.
86. Lin R, Heylbroeck C, Pitha P M, Hiscott J. Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation. Mol Cell Biol. 18:1998;2986-2996.
87. Sato M, Hata N, Asagiri M, Nakaya T, Taniguchi T, Tanaka N. Positive feedback regulation of type-I IFN genes by the IFN-inducible transcription factor IRF-7. FEBS Lett. 441:1998;106-110.
88. Marie I, Durbin J E, Levy D E. Differential viral induction of distinct interferon- α genes by positive feedback through interferon regulatory factor-7. EMBO J. 17:1998;6660-6669.
89. Ronco L V, Karpova A Y, Vidal M, Howley P M. Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity. Genes Dev. 12:1998;2061-2072.